Events
-
-
DUPIXENT@(dupilumab) Patient Story followed by A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
Virtual (Zoom)
by Sandri Johnson, NPJoin us for a virtual discussion with an expert speaker and an adult patient with prurigo nodularis (PN) to Learn more about a treatment option that may help appropriate patients…
-
Clinical Case Discussion: A Pediatric Patient with Uncontrolled Moderate-to-Severe Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age
Virtual (Zoom)
by Brittany Craiglow, MDJoin us for a program discussing a real-world case of a pediatric patient with moderate-to-severe atopic dermatitis (AD) and a treatment option that may help appropriate patients with Type 2…
-
A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
Virtual (Zoom)
by Raffi Tachdjian, MDLearn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
-
-
Type 2 Inflammation: The Story Behind the Symptoms and a Treatment Option for Appropriate Patients
Virtual (Zoom)
by Zakiya Rice, MDLearn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), chronic spontaneous urticaria (CSU), and bullous pemphigoid (BP); which cytokines play…
-
Diagnosing and Assessing Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate Patients with CSU
by Andrew Mastro, PA-CLearn more about the diagnosis and assessment of chronic spontaneous urticaria (CSU), including its clinical manifestations, diagnostic evaluation, assessment scales, and a treatment option for appropriate patients with CSU.
-
Diagnosing and Assessing Uncontrolled Atopic Dermatitis (AD) and a Treatment Option for Appropriate Patients with Uncontrolled Moderate-to-Severe AD
Virtual (Zoom)
by Michael Payette, MDLearn more about how to diagnose and assess uncontrolled moderate-to-severe atopic dermatitis (AD) and a treatment option that may help appropriate patients.
-
A Treatment Option for Appropriate Patients With Prurigo Nodularis and Chronic Spontaneous Urticaria
Virtual (Zoom)
by Melissa Costner, MDLearn more about a treatment option that may help appropriate patients with prurigo nodularis (PN), and chronic spontaneous urticaria (CSU).
-
A Treatment Option for Appropriate Patients With Bullous Pemphigoid
Virtual (Zoom)
by Erin Barrett, MDLearn more about a treatment option that may help appropriate patients with bullous pemphigoid (BP).
-
A Treatment Option for Appropriate Patients With Atopic Dermatitis and Chronic Spontaneous Urticaria
Virtual (Zoom)
by Brad Glick, DOLearn more about a treatment option that may help appropriate patients with atopic dermatitis (AD), and chronic spontaneous urticaria (CSU).
-
Diagnosing and Assessing Uncontrolled Atopic Dermatitis (AD) and a Treatment Option for Appropriate Patients With Uncontrolled Moderate-to- Severe AD
Virtual (Zoom)
by Harrison Nguyen, MDLearn more about how to diagnose and assess uncontrolled moderate-to-severe atopic dermatitis (AD) and a treatment option that may help appropriate patients.
-
Type 2 Inflammation: The Story Behind the Symptoms and a Treatment Option for Appropriate Patients
by Ahmad Amin, MDLearn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), chronic spontaneous urticaria (CSU), and bullous pemphigoid (BP); which cytokines play…
-
Type 2 Inflammation: The Story Behind the Symptoms and a Treatment Option for Appropriate Patients
Virtual (Zoom)
by Michael Payette, MDLearn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), chronic spontaneous urticaria (CSU), and bullous pemphigoid (BP); which cytokines play…
-
Type 2 Inflammation: The Story Behind the Symptoms and a Treatment Option for Appropriate Patients
Virtual (Zoom)
by James Song, MDLearn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), chronic spontaneous urticaria (CSU), and bullous pemphigoid (BP); which cytokines play…
-
Diagnosing and Assessing Prurigo Nodularis (PN) and a Treatment Option for Appropriate Patients With PN
Virtual (Zoom)
by Matthew Bruno, PA-CLearn more about the clinical presentation and diagnostic workup of prurigo nodularis (PN) and a treatment option that may help appropriate patients.
-
A Treatment Option for Appropriate Patients With Prurigo Nodularis
Virtual (Zoom)
by Heather Gates, PA-CLearn more about a treatment option that may help appropriate patients with prurigo nodularis (PN).
-
Diagnosing and Assessing Uncontrolled Atopic Dermatitis (AD) and a Treatment Option for Appropriate Patients With Uncontrolled Moderate-to- Severe AD
Virtual (Zoom)
by Alexandra Golant, MDLearn more about how to diagnose and assess uncontrolled moderate-to-severe atopic dermatitis (AD) and a treatment option that may help appropriate patients.
-
A Treatment Option for Appropriate Patients With Chronic Spontaneous Urticaria
Virtual (Zoom)
by Carsten Hamann, MDLearn more about a treatment option that may help appropriate patients with chronic spontaneous urticaria (CSU).
-
A Treatment Option for Appropriate Patients With Atopic Dermatitis and Prurigo Nodularis
Virtual (Zoom)
by Mona Shahriari, MDLearn more about a treatment option that may help appropriate patients with atopic dermatitis (AD) and prurigo nodularis (PN).
-
Diagnosing and Assessing Bullous Pemphigoid (BP) and a Treatment Option for Appropriate Patients with BP
Virtual (Zoom)
by Daniel Butler, MDLearn more about the diagnosis and assessment of bullous pemphigoid (BP), including clinical manifestations, key laboratory investigations for diagnostic evaluation, consensus-based recommendations, and a treatment option for appropriate patients with…
-
A Treatment Option for Appropriate Patients With Atopic Dermatitis
Virtual (Zoom)
by Adam Friedman, MDLearn more about a treatment option that may help appropriate patients with atopic dermatitis (AD).
-
Type 2 Inflammation: The Story Behind the Symptoms and a Treatment Option for Appropriate Patients
Virtual (Zoom)
by Erin Barrett, MDLearn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), chronic spontaneous urticaria (CSU), and bullous pemphigoid (BP); which cytokines play…